论文部分内容阅读
目的:探究普米克令舒联合博利康尼氧气雾化吸入治疗小儿毛细支气管炎的价值。方法:选取本院2014年5月-2015年5月收治的118例患儿,将其随机分成观察组和对照组各59例。观察组通过普米克令舒联合博利康尼氧气雾化吸入进行治疗,对照组通过地塞米松磷酸钠静脉滴注进行治疗,对比两组患儿临床治疗的效果。结果:观察组的治疗总有效率96.61%,明显优于对照组74.58%,差异具有统计学意义(P<0.05)。两组患儿咳喘和湿啰音消失时间、住院时间进行比较,观察组均短于对照组,差异具有统计学意义(P<0.05)。结论:普米克令舒联合博利康尼氧气雾化吸入的方式治疗小儿毛细支气管炎,疗效满意。
Objective: To investigate the value of pulmicort and combiblipanib aerosol inhalation in the treatment of children with bronchiolitis. Methods: A total of 118 children admitted to our hospital from May 2014 to May 2015 were randomly divided into observation group (59 cases) and control group (59 cases). The observation group was treated with Pulmicort resp. Aerosolized inhalation of propiconazole, and the control group received intravenous infusion of dexamethasone sodium phosphate. The clinical effects of the two groups were compared. Results: The total effective rate of the observation group was 96.61%, which was significantly better than that of the control group (74.58%), the difference was statistically significant (P <0.05). Two groups of children cough and wet rales disappear time, hospital stay were compared, the observation group were shorter than the control group, the difference was statistically significant (P <0.05). Conclusion: Pulmicort respules combined with inhalation of propiconazole on children with bronchiolitis were satisfactory.